Effector Therapeutics Doses First Patient In Second Cohort Of Phase 1B Clinical Trial Of Zotatifin For The Treatment Of COVID-19

  • Nevan Krogan

Press/Media

Period14 Sep 2022

Media coverage

11

Media coverage

  • TitleEffector Therapeutics Doses First Patient In Second Cohort Of Phase 1B Clinical Trial Of Zotatifin For The Treatment Of COVID-19
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date14/09/22
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletBioSpace
    Country/TerritoryUnited States
    Date14/09/22
    URLct.moreover.com/?a=48739535621&p=1gw&v=1&x=66Z5tT85wbl5Fg21IGSNZQ
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletYahoo! Canada
    Country/TerritoryCanada
    Date14/09/22
    URLct.moreover.com/?a=48738717153&p=1gw&v=1&x=6PWXL0tqWwg9rSSmEjTv5Q
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletYahoo! Finance
    Country/TerritoryUnited States
    Date14/09/22
    URLct.moreover.com/?a=48738848498&p=1gw&v=1&x=WUevkDH6EIE2m8mB2pP5Ew
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletMarketScreener.com
    Country/TerritoryUnited States
    Date14/09/22
    URLct.moreover.com/?a=48738657165&p=1gw&v=1&x=YrJFVZRSJC-gP33UE1yI4w
    PersonsNevan Krogan
  • TitleDoses First Patient in Second Cohort of Phase 1b Clinical Trial Of Zotatifin for the Treatment of COVID 19
    Media name/outletMarket News Publishing
    Country/TerritoryUnited States
    Date14/09/22
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletUSA Life Sciences Database
    Country/TerritorySwitzerland
    Date14/09/22
    URLct.moreover.com/?a=48741909215&p=1gw&v=1&x=xHoXVs9RU9a6-K6ggsJYbw
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletGlobeNewswire
    Country/TerritoryUnited States
    Date14/09/22
    URLct.moreover.com/?a=48738655969&p=1gw&v=1&x=wnA4YDMLmTtp9nsEp7oIDQ
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletPrimeNewswire (Top News)
    Country/TerritoryUnited States
    Date14/09/22
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletBizWire Express
    Country/TerritoryIndia
    Date14/09/22
    URLct.moreover.com/?a=48738852470&p=1gw&v=1&x=ZxrGzXYVFpXi2swJzfBYWg
    PersonsNevan Krogan
  • TitleeFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
    Media name/outletForex TV
    Country/TerritoryUnited States
    Date14/09/22
    URLct.moreover.com/?a=48738702452&p=1gw&v=1&x=SJD_lVEb0O-OoPSO4F69Uw
    PersonsNevan Krogan